TherapeuticsMD Inc
General ticker "TXMD" information:
- Sector: Health Care
- Industry: Pharmaceuticals
- Capitalization: $14.7M
TherapeuticsMD Inc does not follow the US Stock Market performance with the rate: -37.9%.
Estimated limits based on current volatility of 4.1%: low 1.06$, high 1.15$
Factors to consider:
- Price in estimated range
- Earnings for 18 months up through Q2 (+1 year) exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2022-12-31 to 2024-12-30
- 2022-12-31 to 2023-12-31 estimated range: [2.11$, 6.96$]
- 2023-12-31 to 2024-12-30 estimated range: [0.96$, 3.26$]
Financial Metrics affecting the TXMD estimates:
- Negative: Non-GAAP EPS, $ of -13.55 <= 0.10
- Negative: Operating cash flow per share per price, % of -7.18 <= 2.35
- Negative: Industry operating cash flow per share per price (median), % of -15.82 <= 3.85
- Positive: 1.03 < Operating profit margin, % of 1.70
- Negative: Industry earnings per price (median), % of -20.11 <= 1.31
Short-term TXMD quotes
Long-term TXMD plot with estimates
Financial data
| YTD | 2020-12-31 | 2021-12-31 | 2022-12-31 |
|---|---|---|---|
| Operating Revenue | $64.87MM | $2.57MM | $69.96MM |
| Operating Expenses | $220.41MM | $82.15MM | $68.77MM |
| Operating Income | $-155.54MM | $-79.58MM | $1.19MM |
| Non-Operating Income | $-27.98MM | $0.27MM | $-0.12MM |
| Interest Expense | $28.58MM | $32.92MM | $0.00MM |
| R&D Expense | $10.43MM | $7.09MM | $0.00MM |
| Income(Loss) | $-183.52MM | $-79.31MM | $1.07MM |
| Other Income(Loss) | $0.00MM | $-93.11MM | $110.92MM |
| Profit(Loss) | $-183.52MM | $-172.41MM | $112.00MM |
| Stockholders Equity | $-124.00MM | $-93.62MM | $35.14MM |
| Inventory | $7.99MM | $7.62MM | $0.00MM |
| Assets | $181.61MM | $169.47MM | $90.46MM |
| Operating Cash Flow | $-159.47MM | $-142.69MM | $-4.08MM |
| Capital expenditure | $1.60MM | $2.22MM | $0.35MM |
| Investing Cash Flow | $-1.60MM | $-2.22MM | $223.48MM |
| Financing Cash Flow | $80.72MM | $129.55MM | $-235.21MM |
| Earnings Per Share* | $-38.58 | $-25.83 | $10.35 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.